SCHEMBL21615958

SCHEMBL21615958

c1ccc(-c2nc(-c3cc(-n4c5ccccc5c5ccccc54)cc4c3sc3ccc5sc6ccccc6c5c34)nc(-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21615969 0.97 KDM4E (0.33) KDM4EATML3MBTL1
SCHEMBL21616000 0.95 KDM4E (0.32) KDM4EATML3MBTL1
SCHEMBL23634612 0.93 ALOX5 (0.32) KDM4EATML3MBTL1
SCHEMBL21616005 0.93 KDM4E (0.31) KDM4EATML3MBTL1
SCHEMBL21615947 0.92 ALOX5 (0.36) KDM4EATML3MBTL1
SCHEMBL21616002 0.92 LIMK1 (0.30) KDM4EATML3MBTL1
SCHEMBL21615950 0.92 KDM4E (0.33) KDM4EATML3MBTL1
SCHEMBL21615985 0.91 KDM4E (0.35) KDM4EATML3MBTL1
SCHEMBL21616017 0.91 LIMK1 (0.34) —
SCHEMBL21616016 0.91 LIMK1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787818-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-17 — — US disclosed
US-11787818-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-17 — — US disclosed
US-20210206778-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-07-08 — — US disclosed
WO-2020009442-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787818-B2 Compound and organic light emitting device comprising the same NCOA4, RCOR1, NR2E3 KDM4E 2322/4885ATM 2863/4885L3MBTL1 1271/4885
US-20210206778-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NCOA4, NR2E3, NR4A1 KDM4E 2312/4885ATM 2659/4885L3MBTL1 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback